Skip to main content
. 2015 Feb 12;2015(2):CD008349. doi: 10.1002/14651858.CD008349.pub3

Subramanian 2013

Methods RCT
Participants Study took place in Canada
32 participants: 16 intervention, 16 control
Inclusion criteria: between 40 and 80 years, sustained single ischaemic or haemorrhagic stroke 6 to 60 months previously, scored 3 to 6 on the Chedoke McMaster Stroke Assessment arm subscale and had no other neurologic or neuromuscular/orthopaedic problems affecting the upper limb and trunk
Exclusion criteria: brainstem or cerebellar lesions, comprehension difficulties and marked apraxia, attention or visual field deficits
Mean (SD) age: intervention group 62 (9.7), control group 60 (11) years
72% male
Stroke details: 47% right hemiparesis
Timing post stroke: intervention group mean (SD) 3.7 (2.2) years, control group 3.0 (1.9) years
Interventions Virtual reality intervention: a 3D virtual environment (CAREN system) simulated a supermarket scene. Participants had to reach for objects in the virtual environment. Training was high in intensity with 72 trials of reaching in each session
Control intervention: pointing at targets in a physical environment
Sessions were 45 minutes for 12 days spaced over 4 weeks
Outcomes Outcomes were recorded at baseline, post‐intervention and 3 months following intervention
Upper limb outcomes: Fugl Meyer, Reaching Performance Scale for Stroke, Wolf Motor Function Test
Other outcomes: Motor Activity Log‐AS
Other outcomes: Motivation Task Evaluation Questionnaire
Other outcomes: kinematic data
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated
Allocation concealment (selection bias) Low risk Managed by external personnel
Blinding of outcome assessment (detection bias) All outcomes Low risk Blinded to allocation
Incomplete outcome data (attrition bias) All outcomes Low risk All completed the assessments. Small number of intervention drop outs and balanced across groups
Selective reporting (reporting bias) Low risk All outcomes reported as per entry on clinical trial registry